본문

  1. Home
12 Results:AA:RECKER R R 0.62 sec.
RSS 
다국어입력
 상세검색
 신착검색
선택출력 선택엑셀내보내기
1
Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass
Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass
Recker, R. R., | Elsevier Inc | 2007 ,
2
Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study
Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study
Recker, R. R., | Elsevier Inc | 2010 ,
3
Issues in modern bone histomorphometry
Issues in modern bone histomorphometry
Recker, R. R, | Elsevier Inc | 2011 ,
4
Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1–84
Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1–84
Recker, R. R., | Elsevier Inc | 2009 ,
5
Bisphosphonate action on bone structure and strength: Preclinical and clinical evidence for ibandronate
Bisphosphonate action on bone structure and strength: Preclinical and clinical evidence for ibandronate
Müller, R., | Elsevier Inc | 2007 ,
6
Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy
Changes in trabecular microarchitecture in postmenopausal women on bisphosphonate therapy
Greenspan, S. L., | Elsevier Inc | 2010 ,
7
Intratrabecular tunneling increases trabecular number throughout the skeleton of ovariectomized rhesus monkeys treated with parathyroid hormone 1–84
Intratrabecular tunneling increases trabecular number throughout the skeleton of ovariectomized rhesus monkeys treated with parathyroid hormone 1–84
Miller, M. A., | Elsevier Inc | 2008 ,
8
Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss
Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss
McClung, M. R., | Elsevier Inc | 2009 ,
9
Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
McClung, M., | Elsevier Inc | 2007 ,
10
Transmenopausal changes in the trabecular bone structure
Transmenopausal changes in the trabecular bone structure
Akhter, M. P., | Elsevier Inc | 2007 ,
처음12이후마지막